The U.S. Court of Appeals for the Eighth Circuit reversed a lower court’s order remanding a case to Missouri state court, as it determined Walmart had showed the amount in controversy exceeded $5 million.

U.S. Court of Appeals Judge Michael Joseph Melloy for the Eighth Circuit concluded Walmart had adequately shown the amount in controversy had exceeded $5 million, specifically that it had sold more than $5 million in cough suppressant products containing dextromethorphan hydrobromide (DXM) and featuring a “non-drowsy” label, in a May 24 opinion.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]